Arthur Lahr is the founder of Kiadis Pharma. Kiadis Pharma has raised $13M in total funding. Latest round: IPO. Based in Netherlands.
Arthur Lahr is the CEO of Kiadis Pharma, a clinical-stage biopharmaceutical company based in Amsterdam, Netherlands. The company specializes in developing innovative cell-based medicines, including 'off-the-shelf' natural killer (NK) cell therapies, for patients with life-threatening diseases such as cancer. Kiadis Pharma was acquired by Sanofi in 2020 and was publicly listed on Euronext.
Full founder directory · Investor directory · Company funding database · Fundraising library